Clinical trial

Effect of Extended Release Torsemide in Patients With Congestive Heart Failure and Overactive Bladder

NCT06206512

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-06-15

PhasePHASE2

Study timeline

Study start (actual)2024-06-15Date precision: day

Registry last updated2026-03-12

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Heart Failureunresolved

Overactive Bladderunresolved

Incontinenceunresolved

Interventions

Extended release torsemideDRUG

Immediate release torsemideDRUG

Extended release torsemide placeboDRUG

Immediate release torsemide placeboDRUG

Sponsors & collaborators

Sarfez Pharmaceuticals, Inc.lead sponsor

Mapped research locations

DallasTexas, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06206512 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.